Diagnostic Accuracy of Serum Bilirubin in the Prediction of Perforated Appendicitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01698099|
Recruitment Status : Completed
First Posted : October 2, 2012
Last Update Posted : October 2, 2012
Hyperbilirubinemia is reported to be a positive predictor in diagnosing perforated appendicitis. Therefore we analysed the diagnostic accuracy of serum bilirubin in discriminating between perforated and simple/no appendicitis.
All consecutive patients undergoing appendectomy for suspected appendicitis from May 2009 to August 2011 were analysed. Primary endpoint was the diagnostic accuracy of serum bilirubin levels to detect perforated appendicitis.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||500 participants|
|Official Title:||Diagnostic Accuracy of Serum Bilirubin in the Prediction of Perforated Appendicitis|
|Study Start Date :||May 2009|
|Actual Primary Completion Date :||August 2011|
|Actual Study Completion Date :||September 2012|
- Diagnostic accuracy of serum bilirubin [ Time Frame: 24h within initial presentation with clinical symptoms ]assessment of the diagnostic accuracy of hyperbilirubinemia (defined as serum bilirubin above 1.1 md/dl)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01698099
|Departement of Visceral- and Transplant Surgery, University of Tuebingen|
|Tuebingen, Germany, 72076|
|Principal Investigator:||Sven Müller, MD||University Hospital Tuebingen|